Pentagon interest in “advanced riot-control agents” has long been an open secret, but just how close we are to seeing these agents in action was revealed in in 2002 When the Sunshine Project, an arms-control group based in Austin, Texas, posted on the Internet a trove of Pentagon documents uncovered through the Freedom of Information Act. Among these was a fifty-page study titled “The Advantages and Limitations of Calmatives for Use as a Non-Lethal Technique,” conducted by Penn State’s Applied Research Laboratory, home of the JNLWD-sponsored Institute for Non-Lethal Defense Technologies.
Penn State’s College of Medicine researchers agreed, contrary to accepted principles of medical ethics, that “the development and use of non-lethal calmative techniques is both achievable and desirable,” and identified a large number of promising drug candidates, including benzodiazepines like Valium, serotonin-reuptake inhibitors like Prozac, and opiate derivatives like morphine, fentanyl, and carfentanyl, the last commonly used by veterinarians to sedate large animals. The only problems they saw were in developing effective delivery vehicles and regulating dosages, but these problems could be solved readily, they recommended, through strategic partnerships with the pharmaceutical industry.
Little more was heard about the Pentagon’s “advanced riot-control agent” program until July 2008, when the Army announced that production was scheduled for its XM1063 “non-lethal personal suppression projectile,” an artillery shell that bursts in midair over its target, scattering 152 canisters over a 100,000-square-foot area, each dispersing a chemical agent as it parachutes down. There are many indications that a calmative, such as fentanyl, is the intended payload-a literal opiate of the masses.